Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells

Chung Heon Ryu(Catholic University of Korea), Sin‐Soo Jeun(The Catholic University of Korea Seoul St. Mary's Hospital)
Journal of Biomedicine and Biotechnology
January 1, 2012
10.1155/2012/987495
Cited by 114

Related Papers

Potential Application of Temozolomide in Mesenchymal Stem Cell-Based TRAIL Gene Therapy Against Malignant Glioma
|Stem Cells Translational Medicine|2014|55
Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma
|Anticancer Research|2019|21
Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma
|Oncology Reports|2021|19